March 17, 2025

Incyte’s Povorcitinib Shows Mixed Phase 3 Results

Incyte's povorcitinib, an oral JAK1 inhibitor, demonstrates promising results in phase 3 trials for hidradenitis suppurativa, potentially offering a new alternative treatment option.

Reuters

March 14, 2025

FDA Warns of Nitrous Oxide Misuse

The FDA warns of serious health risks associated with non-medical use of nitrous oxide, highlighting neurological damage, thromboembolic events, and death.

Reuters

March 14, 2025

FDA Recommends Influenza Vaccine Strains for 2025 to 2026

The FDA has selected influenza vaccine strains for the 2025 to 2026 U.S. flu season, maintaining consistency with prior formulations while incorporating updated epidemiologic and antigenic data to optimize protection.

Conexiant

March 13, 2025

FDA Chief Counsel Resigns Two Days In

U.S. FDA's chief counsel resigns amidst controversy surrounding her appointment and connections to mifepristone during the Biden administration.

Reuters

March 11, 2025

First State to Ban Fluoride in Water

Utah to become first U.S. state to ban fluoride in public water systems, sparking debates on health, policy, and individual choice.

Reuters

March 10, 2025

AI Methods Strengthen Real-World Data Reliability

Researchers assessed the impact of AI-driven methods on real-world data reliability, showing improvements in accuracy, completeness, and traceability

Conexiant

March 07, 2025

New Mexico Measles Cases Hit 30, Health Officials Report

A measles outbreak in New Mexico with 30 cases, including a recent measles-related death, raises concerns and challenges vaccine skepticism. U.S. Health Secretary Robert F. Kennedy Jr. faces a critical test.

Reuters

March 07, 2025

FDA Approves First Xolair Biosimilar

New interchangeable treatment option Omlyclo now available for patients with allergic asthma, chronic hives, nasal polyps, and food allergies; carries same boxed warning for anaphylaxis as original medication.

Conexiant

March 07, 2025

CDC Plans Study on Autism Causes

The CDC is launching a large-scale study on autism prevalence and potential contributing factors. Previous research has found no causal link between vaccines and autism, though diagnoses have risen due to expanded screening and diagnostic criteria.

Reuters